By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MorphoSys AG 

Lena-Christ-Strasse 48

Martinsried  Munich  82152  Germany
Phone: 49-0-89-899-27-0 Fax: 49-0-89-899-27-222


SEARCH JOBS


Industry
Biotechnology






Company News
MorphoSys AG And immatics biotechnologies GmbH Enter Strategic Alliance In Immuno-oncology 8/25/2015 8:28:04 AM
MorphoSys AG CEO Believes Drug Isn't Dead Even After Celgene (CELG) Abandons $818 Million Pact 4/6/2015 5:37:50 AM
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/27/2015 9:06:57 AM
MorphoSys AG And Celgene (CELG) Mutually Agree To End MOR202 Collaboration 3/26/2015 11:00:48 AM
Emergent BioSolutions (EBS) And MorphoSys AG Initiate Phase 1 Clinical Study To Evaluate The Novel Oncology Immunotherapeutic MOR209/ES414 For Prostate Cancer 3/9/2015 7:36:00 AM
MorphoSys AG And Xencor Publish Final Results From Phase 1/2a Trial Of MOR208 (Xmab5574) In CLL/SLL At Xencor Annual Meeting 12/8/2014 7:40:19 AM
MorphoSys AG To Receive Milestone Payment For Guselkumab Phase 3 Program 10/23/2014 7:18:57 AM
MorphoSys AG Acquires Lanthipeptide Technology From Lanthio Pharma 10/15/2014 7:31:19 AM
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million 8/20/2014 6:14:28 AM
MorphoSys AG Provides Update On The Company's Proprietary Drug Portfolio 7/28/2014 7:57:04 AM
12345678910...
//-->